Abstract Body

HIV-superinfection (HIV-SI) occurs when an infected individual acquires a new HIV strain that is phylogenetically distinct from their existing viral population. HIV-SI provides an opportunity to examine the potential role of pre-existing HIV-specific neutralizing antibodies (NAb) in protecting against a subsequent HIV challenge.

Virally unlinked HIV+ individuals in monogamous (n=15) and polygamous relationships (n=6) from the Rural Clinical Cohort (RCC) in southwest Uganda were tested for occurrence of HIV-SI using a previously validated next-generation sequencing (NGS) assay of three viral genomic regions (gag, pol, gp41). One case of linked HIV-SI was identified, and for this case serum samples from before and after the time of the HIV-SI event for both the female, and her husband, were subjected to single-genome amplification (SGA) to generate full-envelope sequences. Full-length Env amplicons from SGA were used to generate pseudoviruses that were tested for their neutralization susceptibility to their homologous serum, as well as their partner’s heterologous serum from before and after HIV-SI.

The linked HIV-SI occurred in a polygamous relationship in which an HIV-infected uncircumcised male superinfected one of his four wives who were all HIV-positive. The male had no indication of HIV-SI in any of the sequences examined. Full-length viral envelope sequences were obtained from the female partner immediately before HIV-SI (Month 0, n=21) and when HIV-SI was first detected three months later (Month +3, n=10). Three of the viral sequences from this later sample were phylogenetically linked to the male’s viruses, thus representing the superinfecting strain. The female’s serum samples prior to HIV-SI displayed moderate NAb activity against her homologous virus. However, her serum prior to HIV-SI, and immediately post HIV-SI, contained no detectable NAb activity to the superinfecting strain. Ten months post HIV-SI, the female had developed a moderate response to the superinfecting strain.

A linked HIV-SI event occurred in a chronically infected female who had moderately potent and broad anti-HIV NAb responses. Despite this, she possessed no detectable NAb response to the superinfecting strain during the estimated HIV-SI window, which potentially could have protected her. This unique case highlights the exciting amount of potential information that even a small number of these linked HIV-SI events could provide.